Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Int J Cancer

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    June 2022
  1. WANG S, Zheng R, Arnold M, Abnet C, et al
    Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34158.
    PubMed     Abstract available

    April 2022
  2. LIU H, Li G, Sturgis EM, Shete S, et al
    Genetic variants in CYP2B6 and HSD17B12 associated with the risk of squamous cell carcinoma of the head and neck.
    Int J Cancer. 2022 Apr 11. doi: 10.1002/ijc.34023.
    PubMed     Abstract available

  3. GARSET-ZAMANI M, Carlander AF, Jakobsen KK, Friborg J, et al
    Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Int J Cancer. 2022;150:1174-1183.
    PubMed     Abstract available

    March 2022
  4. LONG Z, Wang W, Liu W, Wang F, et al
    Trend of nasopharyngeal carcinoma mortality and years of life lost in China and Its Provinces from 2005 to 2020.
    Int J Cancer. 2022 Mar 14. doi: 10.1002/ijc.33998.
    PubMed     Abstract available

  5. RETTIG EM, Faden DL, Sandhu S, Wong K, et al
    Detection of Circulating Tumor Human Papillomavirus DNA Before Diagnosis of HPV-Positive Head and Neck Cancer.
    Int J Cancer. 2022 Mar 9. doi: 10.1002/ijc.33996.
    PubMed     Abstract available

    February 2022
  6. LIU J, Li J, Lin W, Shao D, et al
    Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study.
    Int J Cancer. 2022 Feb 21. doi: 10.1002/ijc.33976.
    PubMed     Abstract available

  7. PATEL KK, Chakravarti P, Chaturvedi P, Dikshit R, et al
    The fifth round of the National Family Health Survey of India 2019 to 2021 reported low screening uptake alarming to strengthen the implementation of early detection services of the cervix, breast and oral cancer.
    Int J Cancer. 2022 Feb 6. doi: 10.1002/ijc.33958.

  8. LIU X, Liu P, Chernock RD, Lang Kuhs KA, et al
    Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2022;150:521-531.
    PubMed     Abstract available

    December 2021
  9. DENEUVE S, Perol O, Dantony E, Guizard AV, et al
    Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France.
    Int J Cancer. 2021 Dec 10. doi: 10.1002/ijc.33896.
    PubMed     Abstract available

    November 2021
  10. LASSEN P, Huang SH, Su J, Waldron J, et al
    Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
    Int J Cancer. 2021 Nov 18. doi: 10.1002/ijc.33876.
    PubMed     Abstract available

    September 2021
  11. DE LA COUR CD, von Buchwald C, Dehlendorff C, Garset-Zamani M, et al
    Low-dose aspirin use and mortality risk in patients with head and neck cancer - a nationwide cohort study of 10,770 patients.
    Int J Cancer. 2021 Sep 18. doi: 10.1002/ijc.33814.
    PubMed     Abstract available

  12. TANAKA H, Suzuki M, Takemoto N, Fukusumi T, et al
    Performance of Oral HPV DNA, Oral HPV mRNA, and Circulating Tumor HPV DNA in the Detection of HPV-Related Oropharyngeal Cancer and Cancer of Unknown Primary.
    Int J Cancer. 2021 Sep 6. doi: 10.1002/ijc.33798.
    PubMed     Abstract available

    May 2021
  13. NARH CT, Dzamalala CP, Mmbaga BT, Menya D, et al
    Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor - Findings from the ESCCAPE multi-country case-control studies.
    Int J Cancer. 2021 May 18. doi: 10.1002/ijc.33688.
    PubMed     Abstract available

    April 2021
  14. BUSSMANN L, Hoffer K, von Bargen CM, Droste C, et al
    Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets.
    Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33606.
    PubMed     Abstract available

    March 2021
  15. NARUSAKA T, Ohara T, Noma K, Nishiwaki N, et al
    Nanog is a promising chemo-resistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
    Int J Cancer. 2021 Mar 4. doi: 10.1002/ijc.33544.
    PubMed     Abstract available

    December 2020
  16. VON WITZLEBEN A, Fehn A, Grages A, EziC J, et al
    Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC).
    Int J Cancer. 2020 Dec 17. doi: 10.1002/ijc.33446.
    PubMed     Abstract available

  17. GETZ KR, Bellile E, Zarins KR, Rullman C, et al
    Statin Use and Head and Neck Squamous Cell Carcinoma Outcomes.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33441.
    PubMed     Abstract available

  18. MMBAGA BT, Mwasamwaja A, Mushi G, Mremi A, et al
    Missing and Decayed Teeth, Oral Hygiene and Dental Staining in relation to Esophageal Cancer Risk: ESCCAPE case-control study in Kilimanjaro Tanzania.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33433.
    PubMed     Abstract available

  19. ANTONSSON A, de Souza M, Wood ZC, Carroll A, et al
    Natural history of oral HPV infection - longitudinal analyses in prospective cohorts from Australia.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33442.
    PubMed     Abstract available

  20. CHEN GH, Liu Z, Ji MF, Pfeiffer RM, et al
    Prospective Assessment of a Nasopharyngeal Carcinoma Risk Score in a Population Undergoing Screening.
    Int J Cancer. 2020 Dec 7. doi: 10.1002/ijc.33424.
    PubMed     Abstract available

  21. YANG CS, Chen XL
    Research on esophageal cancer: with personal perspectives from studies in China and Kenya.
    Int J Cancer. 2020 Dec 3. doi: 10.1002/ijc.33421.
    PubMed     Abstract available

    November 2020
  22. SONG L, Zhang S, Yu S, Ma F, et al
    Cellular heterogeneity landscape in laryngeal squamous cell carcinoma.
    Int J Cancer. 2020;147:2879-2890.
    PubMed     Abstract available

    October 2020
    Esophageal sponge sampling: a promising approach for early detection of esophageal cancer in Africa's high-incidence region.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33372.

    August 2020
  24. BOSETTI C, Carioli G, Santucci C, Bertuccio P, et al
    Global trends in oral and pharyngeal cancer incidence and mortality.
    Int J Cancer. 2020;147:1040-1049.
    PubMed     Abstract available

  25. DALMARTELLO M, Decarli A, Ferraroni M, Bravi F, et al
    Dietary patterns and oral and pharyngeal cancer using latent class analysis.
    Int J Cancer. 2020;147:719-727.
    PubMed     Abstract available

    May 2020
  26. TAY JK, Siow CH, Goh HL, Lim CM, et al
    A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
    Int J Cancer. 2020;146:2923-2931.
    PubMed     Abstract available

    November 2019
  27. VEYER D, Wack M, Mandavit M, Garrigou S, et al
    HPV circulating tumoral DNA quantification by droplet-based digital PCR: a promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Int J Cancer. 2019 Nov 22. doi: 10.1002/ijc.32804.

  28. LEHTINEN M, Apter D, Eriksson T, Harjula K, et al
    Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females - results from a community-randomized trial.
    Int J Cancer. 2019 Nov 17. doi: 10.1002/ijc.32791.
    PubMed     Abstract available

    October 2019
  29. BETTAMPADI D, Villa LL, Lazcano Ponce E, Salmeron J, et al
    Oral Human Papillomavirus Prevalence and Type Distribution by Country (Brazil, Mexico and the United States) and Age among HPV Infection in Men (HIM) Study Participants.
    Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32713.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.